Table 1.
Characteristics | Positive/total (%) | Positive/total (%) | χ2 | P | |
---|---|---|---|---|---|
High | Low | ||||
Gender | |||||
Male | 106/155 | 79 | 27 | 8.388 | 0.004** |
Female | 49/155 | 25 | 24 | ||
Age (years) | |||||
<38 | 43/155 | 25 | 18 | 2.163 | 0.141 |
≥38 | 112/155 | 79 | 33 | ||
Tumor size (cm) | |||||
<5 | 78/155 | 56 | 22 | 1.570 | 0.21 |
≥5 | 77/155 | 48 | 29 | ||
WHO grade# | |||||
I–II | 59/155 | 33 | 26 | 5.378 | 0.02* |
III–IV | 96/155 | 71 | 25 | ||
Ki-67 (%) | |||||
<10 | 86/155 | 53 | 33 | 2.617 | 0.106 |
≥10 | 69/155 | 51 | 18 | ||
p53 (%) | |||||
<10 | 71/155 | 36 | 35 | 15.946 | 0.000*** |
≥10 | 84/155 | 68 | 16 | ||
KPS score | |||||
<70 | 66/155 | 42 | 24 | 0.623 | 0.430 |
≥70 | 89/155 | 62 | 27 |
Classified by the 2007 WHO (World Health Organization) Classification of Tumors of the Nervous System;
statistically significant (P<0.05);
statistically significant (P<0.01);
statistically significant (P<0.00).
KPS – Karnofsky performance scale.